Ionis and affiliated programs are not the only part of the compliance picture drawing scrutiny—pharma’s operational complexity is pushing more activity into governance, contracts, and auditable analytics. A guidance-focused piece highlighted how companies are moving toward more structured fair market value processes as they scale healthcare professional engagement, emphasizing defensible, industry-based rate inputs and documentation that third parties can replicate during audits.